Literature DB >> 3539162

Long term improvement in global left ventricular function after early thrombolytic treatment in acute myocardial infarction. Report of a randomised multicentre trial of intracoronary streptokinase in acute myocardial infarction.

J C Res, M L Simoons, E E van der Wall, M J van Eenige, F Vermeer, F W Verheugt, W Wijns, S Braat, W J Remme, P W Serruys.   

Abstract

The effect of reperfusion achieved by early intracoronary streptokinase in acute myocardial infarction on left ventricular function was studied in 533 patients enrolled in a prospective randomised multicentre study. Two hundred and sixty four patients were allocated to conventional treatment and 269 patients to thrombolysis. At the end of the procedure patency of the infarct related vessel was achieved in 198 (85%) of 234 patients in whom coronary angiography was performed. The median interval from onset of symptoms till the angiographic documentation of patency was 200 minutes. Data were analysed according to the original treatment allocation. Global left ventricular ejection fraction was determined by radionuclide angiography in 418 patients within two days of admission, in 361 patients after two weeks, and in 307 patients after three months. Global left ventricular function remained unchanged throughout the observation period in the control group, whereas it improved during the first two weeks in patients allocated to thrombolytic treatment. Improved function in these patients persisted up to three months after the infarction. Global left ventricular ejection fraction was significantly better in the thrombolysis group than in the control group at two days, two weeks, and at three months. In patients with anterior myocardial infarction the left ventricular ejection fraction was 9% better than in the control group at two weeks and at three months. In the patients with inferior myocardial infarction differences between the two treatment groups were smaller because of photon attenuation within the body. Angiographic evidence suggested that the improvement in function seen after thrombolysis is indeed associated with the patency of the infarct related artery.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3539162      PMCID: PMC1236886          DOI: 10.1136/hrt.56.5.414

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  23 in total

1.  A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction.

Authors:  J L Anderson; H W Marshall; B E Bray; J R Lutz; P R Frederick; F G Yanowitz; F L Datz; S C Klausner; A D Hagan
Journal:  N Engl J Med       Date:  1983-06-02       Impact factor: 91.245

2.  Coronary recanalization in acute myocardial infarction: immediate results and potential risks.

Authors:  P W Serruys; M van den Brand; T E Hooghoudt; M L Simoons; P Fioretti; J Ruiter; P W Fels; P G Hugenholtz
Journal:  Eur Heart J       Date:  1982-10       Impact factor: 29.983

Review 3.  Thrombolytic therapy for acute myocardial infarction: quo vadis? A review of the recent literature.

Authors:  P G Hugenholtz; P Rentrop
Journal:  Eur Heart J       Date:  1982-10       Impact factor: 29.983

4.  Clinical course after attempted thrombolysis in myocardial infarction. Results of pilot studies and preliminary data from a randomized trial.

Authors:  P Fioretti; M L Simoons; P W Serruys; M van den Brand; P W Fels; P G Hugenholtz
Journal:  Eur Heart J       Date:  1982-10       Impact factor: 29.983

5.  Intravenous short-term infusion of streptokinase in acute myocardial infarction.

Authors:  R Schröder; G Biamino; E R von Leitner; T Linderer; T Brüggemann; J Heitz; H F Vöhringer; K Wegscheider
Journal:  Circulation       Date:  1983-03       Impact factor: 29.690

6.  Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction.

Authors:  P W Serruys; M L Simoons; H Suryapranata; F Vermeer; W Wijns; M van den Brand; F Bär; C Zwaan; X H Krauss; W J Remme
Journal:  J Am Coll Cardiol       Date:  1986-04       Impact factor: 24.094

7.  A new design for randomized clinical trials.

Authors:  M Zelen
Journal:  N Engl J Med       Date:  1979-05-31       Impact factor: 91.245

8.  Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial.

Authors:  F Khaja; J A Walton; J F Brymer; E Lo; L Osterberger; W W O'Neill; H T Colfer; R Weiss; T Lee; T Kurian; A D Goldberg; B Pitt; S Goldstein
Journal:  N Engl J Med       Date:  1983-06-02       Impact factor: 91.245

9.  Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction.

Authors:  W J Rogers; J A Mantle; W P Hood; W A Baxley; P L Whitlow; R C Reeves; B Soto
Journal:  Circulation       Date:  1983-11       Impact factor: 29.690

Review 10.  The stunned myocardium: prolonged, postischemic ventricular dysfunction.

Authors:  E Braunwald; R A Kloner
Journal:  Circulation       Date:  1982-12       Impact factor: 29.690

View more
  2 in total

Review 1.  Infarct sizing by scintigraphic techniques and nuclear magnetic resonance imaging.

Authors:  E E van der Wall; M G Niemeyer; A de Roos; A V Bruschke; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1990

2.  Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The Netherlands.

Authors:  F Vermeer; M L Simoons; C de Zwaan; G A van Es; F W Verheugt; A van der Laarse; D C van Hoogenhuyze; A J Azar; F J van Dalen; J Lubsen
Journal:  Br Heart J       Date:  1988-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.